Last reviewed · How we verify
NCT02911883
Evaluation of the Repeatability and Reproducibility of AngioVue
trial testing Optical Coherence Tomography Angiography in Normal, Glaucoma & Retinal Pathology in 70 participants. Completed in 2 February 2017.
1 February 2017
Quick facts
| Lead sponsor | Optovue |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 29 August 2016 |
| Primary completion | 1 February 2017 |
| Estimated completion | 2 February 2017 |
Drugs / interventions tested
- Optical Coherence Tomography Angiography
Conditions studied
- Normal, Glaucoma & Retinal Pathology — all drugs for Normal, Glaucoma & Retinal Pathology →
Sponsor
Optovue
Who can join
18 and older, any sex, with Normal, Glaucoma & Retinal Pathology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess the repeatability and reproducibility of measurements of the vascular structures and the anatomical structures of the posterior pole of the eye based on AngioVue volume scans in normal subjects, glaucoma patients, and retina patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02911883
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Optical Coherence Tomography Angiography
Trials testing the same drug.
- NCT07060196 — The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration · not yet recruiting
- NCT06031350 — Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomogr · completed
- NCT04546997 — Study of Retinal Vascular Changes After Ocular Blunt Trauma · completed
- NCT04443231 — Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation · completed
- NCT03635671 — Diabetic Retinopathy and Subclinical Signs of Disease Transition · terminated
Other Optovue trials
Trials by the same sponsor.
- NCT04437082 — Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography) · completed
- NCT03887104 — Data Collection of OCT and OCTA-based Ocular Measurements · completed
- NCT03852485 — Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate · completed
- NCT03859310 — Precision of OCT and OCTA-based Ocular Measurements · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02911883 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Optovue
- Last refreshed: 20 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02911883.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing